AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. RDHL
  4. [EFFECT] Redhill Biopharma Ltd. SEC Filing

[EFFECT] Redhill Biopharma Ltd. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 2, 2025 4:00 P.M.
Form: F-1
CIK: 0001553846
Company Name: RedHill Biopharma Ltd.
File Number: 333-288324

Source:

Stock RDHL logo
Redhill Biopharm

NASDAQ:RDHL

RDHL Rankings

#6416 Ranked by Market Cap
N/A Ranked by Dividends
#204 Top Gainer

RDHL Latest News

Aug 18, 2025
RedHill Received Talicia® Licensing Payments Totaling $1.1 Million
Jul 21, 2025
RedHill Receives Positive FDA Feedback on Pathway to Approval of Groundbreaking RHB-204 for Crohn's Disease
Jul 1, 2025
RedHill Biopharma Announces Recruitment Initiated into Expanded Phase 2 Opaganib/Darolutamide Combination Study in Advanced Prostate Cancer
May 13, 2025
RedHill Biopharma Secures Kukbo Asset Freeze Following RedHill's $8.25 Million Plus Legal Fees New York Supreme Court Summary Judgment Win
May 2, 2025
RedHill-Supported Medscape H. Pylori Educational Program to Launch at Major Gastroenterology Congress

RDHL Latest SEC Filings

Aug 18, 2025
[6-K] Redhill Biopharma Ltd. Current Report (Foreign Issuer)
Aug 14, 2025
[6-K] Redhill Biopharma Ltd. Current Report (Foreign Issuer)
Jul 21, 2025
[6-K] Redhill Biopharma Ltd. Current Report (Foreign Issuer)
Jul 2, 2025
[424B3] Redhill Biopharma Ltd. Prospectus Filed Pursuant to Rule 424(b)(3)
Jul 1, 2025
[6-K] Redhill Biopharma Ltd. Current Report (Foreign Issuer)

RDHL Stock Data

3.19M
2.30M
4.3%
1.07%
Drug Manufacturers - Specialty & Generic
Healthcare
Israel
Tel Aviv